RELATED CONTENT
September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and ...
September 17, 2021 
August 30, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions ...
August 30, 2021 
March 8, 2021 — IBA (Ion Beam Applications S.A., EURONEXT) and NorthStar Medical Radioisotopes, LLC, announced a ...
March 08, 2021 
October 23, 2020 — IBA, a leading provider of proton therapy solutions, will highlight how its Proteus solutions as well ...
October 23, 2020 
September 25, 2020 — IBA (Ion Beam Applications SA) announced that more than 100,000 patients have now been treated with ...
September 25, 2020 
January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down ...
January 29, 2020 
December 12, 2019 — IBA (Ion Beam Applications SA) announced that the University of Florida Health Proton Therapy ...
December 12, 2019 
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago.
September 17, 2019 
IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming American Society for Radiation Oncology (ASTRO) congress, Sept. 15-19 in Chicago.
September 12, 2019 
IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution with The University of Kansas Health System. The contract includes a plan for a possible extension with a second ProteusOne unit in the future. The proton therapy center will be built at the Main Campus of The University of Kansas Health System in Kansas City, Kansas. Construction is anticipated to begin later this year.
August 06, 2019